期刊文献+

可分剂量甲磺酸二氢麦角碱缓释微囊片的制备及体外释放机制的研究 被引量:2

Studies on Preparation and Dissolution Mechanism in Vitro of Ergoloid Mesylates Divided Dose Tablet of Extended-Release Microcapsule
原文传递
导出
摘要 目的对可分剂量甲磺酸二氢麦角碱缓释微囊片(EDDTEM)的处方进行研究,并研究其体外释放机制。方法以海藻酸钠-壳聚糖为囊材,采用复凝聚法制备甲磺酸二氢麦角碱缓释微囊(EEM)并压制成片,采用正交设计实验优化处方。结果EEM的最优处方为:海藻酸钠与药物比例为6∶1,海藻酸钠-壳聚糖比例为4∶1,海藻酸钠浓度为2.5%。所制缓释片释药行为符合Higuchi方程,释药机理为扩散和溶蚀并存。结论EDDTEM具有良好的体外缓释效果,可进一步进行体内释药行为考察。 OBJECTIVE To study prescription of ergoloid mesylates divided dose tablet of extended-release microcapsule(EDDTEM) and inspect dissolution mechanism in vitro.METHODS Ergoloid mesylates extended-release microcapsule(EEM) were prepared with alginate-chitosan as capsule wall material.The orthogonal experiment was designed to screen prescription.RESULTS The optimization of prescription was as follows:the proportion of alginate to drug is 6∶1,the proportion of alginate to chitosan is 4∶1,the concentration of alginate is 2.5%.The release behavior of EDDTEM was coincident with Higuchi equation.The dissolution mechanism were both diffusion and corrosion.CONCLUSION EDDTEM had good effect of extended-release in vitro and the release behavior in vivo needs to be inspected.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2010年第3期231-235,共5页 Chinese Journal of Modern Applied Pharmacy
关键词 甲磺酸二氢麦角碱 壳聚糖 海藻酸钠 缓释微囊 释放机制 ergoloid mesylates chitosan alginate extended-release microcapsule dissolution mechanism
  • 相关文献

参考文献7

  • 1王志海,尹小健,林常青.甲磺酸二氢麦角碱用于脑梗死恢复期病人的临床观察[J].中西医结合心脑血管病杂志,2004,2(9):519-520. 被引量:4
  • 2THIMMA R T, TAMMSHETTI S. Study ot complex coacervation of gelatin with sodium carboxymethy guar gum: microencapsulation of clove oil and sulphamethoxazole [J].J Microencapsulation, 2003, 20(2): 203-206.
  • 3梁广华,潘静岚.依舒佳林缓释片释放度研究[J].广东药学院学报,2005,21(3):276-278. 被引量:3
  • 4CHIDAMBARAM N, PORTER W, FLOOD K, et al. Formulation and charact-erization of new layered diffusional matrices for zero-order sustainedrelease [J]. J Control Release, 1998, 52(1/2): 149-153.
  • 5Department of Health and Human Services. Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms [M]. Center for Drug Evaluation and Research (CDER), ROCKVILLE, MD: 1997.
  • 6SATHE P, TSONG Y, SHAH V P, et al. In vitro dissolution profile comparison: statistics and analysis, model dependent approach [J]. Pharm Res, 1996, 13(12): 1799-1805.
  • 7FANH ZHANGQQ.The research progress of alginate in the application ofpharmaceutics .中国药房,2006,17(6):465-466.

二级参考文献9

  • 1Le Poncin- Lafitte M. Simultaneous study of harem odynamic, metabolic, and behavioral sequelae in a model of cerebral is chasm is in aged rats: Effects of nicergoline[J ]. Gerontology,1984,30:109.
  • 2FM Calonna, G Matrice, Y Fryda, el al. The use of a sustained -release drug in gerontology[J]. Gaz Med France,1990,5(83) :412 - 418.
  • 3Bromocriptine, dihydroergotoxine, methysergide, d - LSD,CF25 - 397, AND 29 - 397: Effects on the metabolism of the biogenic amines in brain of the rat [ J ]. Psychopharmacology, 1978,57:227 - 237.
  • 4Effect of Dihydroergotoxine on cylic - AMP - generating systems in rat[J]. Cerebral Cortex Slices Gerontology, 1978,24(Suppl. 1) :94 - 105.
  • 5Benzi G De. Effect of lysergide and nicergoline on glucose metabolism investigated on the dog brain isolated in situs[J].J Pharm Sci,1972,61:348.
  • 6MrsuljaB kovacevicM VujicD.氢化麦角碱治疗缺血性脑血管病的生化和临床[J].迈特发医药特讯,1996,3:5-5.
  • 7.中国药典(2000年版二部)[S].,2000.附录64.
  • 8王慎付,陆永文.30例血管性痴呆的成因探讨[J].中国神经精神疾病杂志,1998,24(2):107-109. 被引量:4
  • 9陈道文,李作汉,邵伟波.氢化麦角碱治疗急性缺血性脑血管病的临床观察[J].临床神经病学杂志,1999,12(3):183-184. 被引量:4

共引文献5

同被引文献16

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部